Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Tobacco Use Cessation Clinical Trial

Official title:

Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04827420
• Other study ID #: 2020-0532
• Secondary ID: 1UG3HL151302-01
• Status: Recruiting
• Phase: N/A
• Start date: September 1, 2021
• Est. completion date: August 1, 2027

Study information

• Verified date: May 2023
• Source: University of Illinois at Chicago
• Contact: Alicia Matthews, Phd
• Phone: 3129967885
• Email: aliciak[@]uic.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Demonstrating the feasibility, effectiveness, and cost-effectiveness of electronically delivered smoking cessation interventions via patient portals in Federally Qualified Health Care (FQHC) settings has the potential for wide-spread dissemination and significant public health impact. on patient populations with demonstrated high rates of smoking. The specific aims of are to: UG3: Aim 1. Examine the burden of tobacco use and its influence on pulmonary health disparities (lung cancer, COPD, and asthma) in the patient population and the economically disadvantaged and racially segregated catchment areas of Mile Square Health Centers. Aim 2: Evaluate among MSHC patients and health care providers, knowledge, attitudes, barriers and facilitators related to smoking cessation, engagement with the tobacco quit line, linkage to the tobacco quit line via a patient health portal and receipt of patient navigation to facilitate access to the tobacco quit line. Aim 3: Evaluate the use of community engagement strategies to increase uptake of the UI Health Patient Portal among low-income patients receiving care at Mile Square Health Center. Aim 4: Test the acceptability, feasibility, and capacity of Mile Square Health to deliver Mi Quit CARE, an evidence-based and multi-level intervention to increase engagement with the quit line via the UI Health Portal. UH3: Aim 1: Determine the effectiveness Mi Quit CARE compared to standard of care in increasing patient engagement with the Illinois tobacco quitline and subsequent smoking cessation outcomes. Aim 2: Evaluate the scalability of Mi Quit CARE to multiple sites within the UI Health FQHC Mile Square clinic network and by translating the intervention to Spanish. Aim 3: Examine the cost effectiveness of Mi Quit CARE on smoking cessation outcomes compared to standard of care among a high risk FQHC population.

Description:

A detailed description can be found at :Matthews, A. K., Watson, K. S., Duangchan, C., Steffen, A., & Winn, R. (2021). A Study Protocol for Increasing Access to Smoking Cessation Treatments for Low-Income Minority Smokers. Frontiers in Public Health, 9, 762784

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 506
• Est. completion date: August 1, 2027
• Est. primary completion date: August 1, 2027
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• aged 18 years and older
• current smoker
• English speaking
• All genders.

Exclusion Criteria:

• aged less than 18
• non-smoker
• non English speaking
• inability to provide informed consent

Related Conditions & MeSH terms

• Tobacco Use Cessation

Intervention

Behavioral:
• Mi Quit Care
Demonstrating the feasibility, effectiveness, and cost-effectiveness of electronically delivered smoking cessation interventions via patient portals in Federally Qualified Health Care (FQHC) settings has the potential for wide-spread dissemination and significant public health impact. on patient populations with demonstrated high rates of smoking.

Locations

Country	Name	City	State
United States	University of Illinois at Chicago	Chicago	Illinois

Sponsors (2)

Lead Sponsor	Collaborator
University of Illinois at Chicago	National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Received Treatment	Number of participants who received smoking cessation counseling	6 months
Secondary	Smoking Cessation	Number of participants who quit smoking	6 months